首页 | 本学科首页   官方微博 | 高级检索  
     

ER和MDM2及ERK1/2信号通与卵巢癌耐药关系的研究
引用本文:王劲欧,吕庆杰,曹薇,姜卫国,宋继谒,齐亚飞. ER和MDM2及ERK1/2信号通与卵巢癌耐药关系的研究[J]. 中华肿瘤防治杂志, 2008, 15(19): 1458-1462
作者姓名:王劲欧  吕庆杰  曹薇  姜卫国  宋继谒  齐亚飞
作者单位:1. 中国医科大学附属盛京医院病理科,辽宁,沈阳,110004
2. 中国医科大学基础医学院病理教研室,辽宁,沈阳,110001
基金项目:辽宁省博士科研启动基金,沈阳市科技局资助项目 
摘    要:
目的:探讨ER、MDM2和ERK1/2信号通路在卵巢癌中的相关性及与卵巢癌耐药的关系。方法:采用免疫组织化学SP法检测40例卵巢癌标本中ER、MDM2及P-糖蛋白(P-gp)的表达水平;采用MTT比色分析法检测该40例标本对紫杉醇(PTX)、表柔比星(EADM)、顺铂(DDP)和卡铂(CBP)的药物敏感性;通过酶活性测定,检测ERK1/2酶活性。结果:PTX和EADM耐药者ERK1/2酶活性分别增高1.5倍,P值分别为0.015和0.004;ERK1/2酶活性与PTX和EADM的抑制率负相关,r分别为-0.531和-0.488,P<0.01;ER和MDM2不同表达水平间ERK1/2酶活性差异均有统计学意义,P值分别为0.001和0.034;P-gp阳性组ERK1/2酶活性是阴性组的1.4倍,P=0.022;P-gp阴性组PTX和EADM的抑制率分别是阳性组的1.5和2.0倍,P值分别为0.021和0.004;P-gp与MDM2的表达正相关,r=0.396,P<0.05;MDM2不同表达水平,PTX和EADM抑制率的差异有统计学意义,P值分别为0.024和0.039;ER与MDM2的表达正相关,r=0.671,P<0.01;DDP和CBP在本实验中差异无统计学意义。结论:ER、MDM2及ERK1/2激酶活性之间存在正相关性;ERK1/2激酶活性和MDM2的表达均与P-gp的表达正相关;卵巢癌PTX和EADM耐药的产生与ERK1/2酶活性的升高和P-gp及MDM2表达的增强有关。

关 键 词:卵巢肿瘤  受体  雌激素  核蛋白质类  蛋白激酶类  抗药性  肿瘤

Relationship between ER, MDM2 and ERK1/2 signal pathway and drug resistance in ovarian cancer
WANG Jin-ou,LU Qing-jie,CAO Wei,JIANG Wei-guo,SONG Ji-ye,QI Ya-fei. Relationship between ER, MDM2 and ERK1/2 signal pathway and drug resistance in ovarian cancer[J]. Chinese Journal of Cancer Prevention and Treatment, 2008, 15(19): 1458-1462
Authors:WANG Jin-ou  LU Qing-jie  CAO Wei  JIANG Wei-guo  SONG Ji-ye  QI Ya-fei
Abstract:
OBJECTIVE:To explore the relationship between the expressions of ER,MDM2 and the activation of ERK1/2 signal pathway and drug resistance in ovarian cancer,respectively.METHODS:SP immunohistochemistry was used to detect the expressions of ER,MDM2 and P-gp in 40 ovarian cancer specimens;MTT assay was used to investigate the susceptibilities of the 40 ovarian cancer tissues to PTX,EADM,DDP and CBP;and in the meanwhile the change of ERK1/2 activity was examed to measure its efficiency of phosphate transferase.RESULTS:Compared with the samples sensitive to PTX and EADM,ERK1/2 activity was 1.5-fold higher respectively for the samples resistant to PTX and EADM,and P were 0.015 and 0.004 respectively.ERK1/2 activity was inversely correlated with the inhibition rates of PTX and EADM.r were-0.531 and-0.488 respectively,P<0.01.To different levels of ER and MDM2,the differences of ERK1/2 activities were significant,Pwere 0.001 and 0.034 respectively.In the P-gp positive cases,the ERK1/2 activity was 1.4-fold higher than that in the P-gp negative cases(P=0.022),and in P-gp negative samples,the inhibition rates of PTX and EADM were 1.5 and 2.0-fold higher respectively than those of the P-gp positive samples(P were 0.021 and 0.004,respectively).P-gp was positively correlated with MDM2,r=0.396,P<0.05.To the different levels of MDM2 expression,the differences of inhibition rates of PTX and EADM were significant(P were 0.024 and 0.039 respectively).The expression of ER was positively correlated with the expression of MDM2,r=0.671,P<0.01.In this study,there were no significant consequences for DDP and CBP.CONCLUSION:ER,MDM2 and ERK1/2 activity are positively correlated with each other,ERK1/2 activity and MDM2 expression are both positively correlated with P-gp expression,the drug resistance of PTX and EADM is correlated with the enhancement of ERK1/2 activity and the expressions of P-gp and MDM2.
Keywords:ovarian neoplasms  receptors  estrogen  nuclear proteins  protein kinases  drug resistance  neoplasms
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号